Baker Tilly Wealth Management LLC Raises Holdings in Haleon plc (NYSE:HLN)

Baker Tilly Wealth Management LLC raised its position in shares of Haleon plc (NYSE:HLN) by 13.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 67,384 shares of the company’s stock after acquiring an additional 8,079 shares during the period. Baker Tilly Wealth Management LLC’s holdings in Haleon were worth $643,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Fortitude Family Office LLC purchased a new stake in shares of Haleon during the 3rd quarter worth about $28,000. Versant Capital Management Inc lifted its position in Haleon by 2,029.1% during the fourth quarter. Versant Capital Management Inc now owns 3,513 shares of the company’s stock valued at $34,000 after buying an additional 3,348 shares in the last quarter. Toronto Dominion Bank grew its stake in Haleon by 3,470.0% during the third quarter. Toronto Dominion Bank now owns 3,570 shares of the company’s stock worth $38,000 after buying an additional 3,470 shares during the period. Prospera Private Wealth LLC acquired a new stake in shares of Haleon in the third quarter worth $57,000. Finally, BOKF NA raised its stake in shares of Haleon by 68.8% in the 2nd quarter. BOKF NA now owns 6,972 shares of the company’s stock valued at $58,000 after acquiring an additional 2,842 shares during the period. 6.67% of the stock is currently owned by institutional investors and hedge funds.

Haleon Stock Down 3.2 %

Shares of Haleon stock traded down $0.30 during trading hours on Friday, hitting $9.19. 4,134,510 shares of the company’s stock traded hands, compared to its average volume of 6,814,480. Haleon plc has a twelve month low of $7.89 and a twelve month high of $10.80. The company has a market cap of $41.60 billion, a PE ratio of 27.03, a PEG ratio of 2.95 and a beta of 0.29. The company has a quick ratio of 0.58, a current ratio of 0.84 and a debt-to-equity ratio of 0.44. The stock has a 50 day simple moving average of $9.61 and a 200-day simple moving average of $9.67.

Analysts Set New Price Targets

Several analysts recently issued reports on HLN shares. UBS Group upgraded Haleon to a “strong-buy” rating in a report on Tuesday, October 1st. Sanford C. Bernstein lowered Haleon from an “outperform” rating to a “market perform” rating in a research note on Wednesday. Finally, Morgan Stanley lowered Haleon from an “overweight” rating to an “equal weight” rating in a research report on Friday. Three equities research analysts have rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $10.95.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.